Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | GLS | O94925 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL427520 | 0.82 | SMN1; SMN2 (0.37) | MEN1KMT2ASMN1; SMN2ALDH1A1HTT | |
| SCHEMBL22337568 | 0.80 | SMN1; SMN2 (0.36) | MEN1KMT2ASMN1; SMN2ALDH1A1HTT | |
| SCHEMBL255124 | 0.78 | SMN1; SMN2 (0.39) | MEN1KMT2ASMN1; SMN2HTTGLS | |
| SCHEMBL20320341 | 0.78 | SMN1; SMN2 (0.33) | MEN1KMT2ASMN1; SMN2ALDH1A1HTT | |
| SCHEMBL3436871 | 0.76 | PKM (0.45) | MEN1KMT2ASMN1; SMN2ALDH1A1HTT | |
| SCHEMBL20320344 | 0.75 | SMN1; SMN2 (0.33) | SMN1; SMN2 | |
| SCHEMBL20320345 | 0.75 | SMN1; SMN2 (0.33) | MEN1KMT2ASMN1; SMN2ALDH1A1GLS | |
| SCHEMBL20320338 | 0.75 | PDE2A (0.39) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL20320349 | 0.75 | SMN1; SMN2 (0.33) | MEN1KMT2ASMN1; SMN2ALDH1A1GLS | |
| SCHEMBL20320342 | 0.74 | SMN1; SMN2 (0.33) | SMN1; SMN2GLS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AG (DE) | 2020-12-17 | — | — | US | disclosed |
| WO-2018114596-A1 | SUBSTITUTED HETEROARYL PYRROLONES AND SALTS THEREOF AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | DDT, NOTUM, AGPS | MEN1 3916/4885KMT2A 2086/4885SMN1; SMN2 4626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.